04:06 PM EST, 11/22/2024 (MT Newswires) -- Jon Faiz Kayyem, Director, on November 19, 2024, executed a purchase for 107,186 shares in Inhibrx Biosciences ( INBX ) for $1,523,620. Following the Form 4 filing with the SEC, Kayyem has control over a total of 69,843 shares of the company, with 69,843 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2007919/000200791924000064/xslF345X05/wk-form4_1732309427.xml